Higher Starting Dose of Ciclosporin Optimized Therapeutic Levels in Patients Receiving Phenytoin for Busulfan-induced Seizure Prophylaxis

BACKGROUND : Despite understanding the drug-drug interaction between phenytoin and ciclosporin (CsA), there is no recommended CsA dosing in patients receiving phenytoin as seizure prophylaxis in busulfan-based conditioning regimens. This drug-drug interaction has resulted in patients with sub-therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ying Shi, Chong, Mui Fong, Ng, Vin Cci, Ho, Aloysius, Ng, Hong Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847281/
https://www.ncbi.nlm.nih.gov/pubmed/36711059
http://dx.doi.org/10.31547/bct-2020-022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847281/
https://www.ncbi.nlm.nih.gov/pubmed/36711059
http://dx.doi.org/10.31547/bct-2020-022

Ejemplares similares